Skip to content
10-Q

Quarterly Report

PROLOR BIOTECH, INC.

0001144204-13-027961

← back to feed
Filed
May 10, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Apr 30, 2013 63.68M sh
Capex Q1 2013 · Mar 31, 2013 $6.18K
Capex Q1 2013 · Mar 31, 2013 $1.75M
Capex Q1 2013 · Mar 31, 2012 $117.12K
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$4.05M
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$54.44M
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$4.71M
Cash And Equivalents Q1 2013 · Mar 31, 2013 $24.73M
Cash And Equivalents Q1 2013 · Dec 31, 2012 $23.85M
Cash And Equivalents Q1 2013 · Mar 31, 2012 $7.25M
Cash And Equivalents Q1 2013 · Dec 31, 2011 $13.26M
Cash And Equivalents Q1 2013 · May 30, 2005 $0
Stockholders Equity Q1 2013 · Mar 31, 2013 $29.45M
Stockholders Equity Q1 2013 · Dec 31, 2012 $33.2M
Current Liabilities Q1 2013 · Mar 31, 2013 $1.81M
Current Liabilities Q1 2013 · Dec 31, 2012 $2.34M
Current Assets Q1 2013 · Mar 31, 2013 $30.28M
Current Assets Q1 2013 · Dec 31, 2012 $34.44M
Total Assets Q1 2013 · Mar 31, 2013 $31.72M
Total Assets Q1 2013 · Dec 31, 2012 $35.92M
Sga Expense Q1 2013 · Mar 31, 2013 $1.53M
Sga Expense Q1 2013 · Mar 31, 2013 $21.64M
Sga Expense Q1 2013 · Mar 31, 2012 $789.78K
Rd Expense Q1 2013 · Mar 31, 2013 $3.2M
Rd Expense Q1 2013 · Mar 31, 2013 $51.55M
Rd Expense Q1 2013 · Mar 31, 2012 $4.3M
Net Income Q1 2013 · Mar 31, 2013 −$4.74M
Net Income Q1 2013 · Mar 31, 2013 −$72.66M
Net Income Q1 2013 · Mar 31, 2012 −$5M
Operating Income Q1 2013 · Mar 31, 2013 −$4.73M
Operating Income Q1 2013 · Mar 31, 2013 −$73.18M
Operating Income Q1 2013 · Mar 31, 2012 −$5.09M
Revenue Q1 2013 · Mar 31, 2013 $0
Revenue Q1 2013 · Mar 31, 2013 $0
Revenue Q1 2013 · Mar 31, 2012 $0